Acura Pharmaceuticals, Inc. Announces the Passing of Andrew Reddick, President & CEO

PALATINE, Ill., April 29, 2011 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) announced today with great sadness that Andrew D. Reddick, its President and Chief Executive Officer and a Director, passed away on April 28, 2011. He was 58 years old. The Board of Directors and all Acura employees extend our deepest condolences to the Reddick family.
MORE ON THIS TOPIC